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NG2 glia are vital for the myelination of axons in the brain and spinal cord. Many NG2 
cells receive synaptic inputs from neurons through neurotransmitters such as glutamate and 
GABA, but the consequences of this input have remained unclear. Interestingly, NG2 cells 
express voltage-dependent Ca2+ channels and transcripts encoding SNARE proteins that are 
necessary for vesicle docking in neurons. We therefore hypothesized that NG2 cells respond to 
neuronal synaptic inputs by releasing bioactive molecules in a Ca2+-dependent manner. To test 
this, we generated double transgenic mice in which a cre-inducible botulinum toxin (BoNT/B) is 
constitutively expressed by NG2 cells (IBOT:NG2cre mice). In the IBOT:NG2cre line, BoNT/B 
cleaves vesicle-associated membrane proteins (VAMPs) in NG2 cells and their progeny. 
IBOT:NG2cre mice exhibited a robust phenotype, with severe motor defects and translucent 
spinal cords suggestive of severe hypomyelination. Immunostaining for MBP supported these 
findings, as IBOT:NG2cre spinal cord sections displayed pronounced hypomyelination 
throughout dorsal and anterolateral funiculi, particularly in the ventral region of the dorsal 
column, which notably contains the corticospinal tract. Staining for the oligodendrocyte antigen 
CC1 and with NG2 also showed a significant decrease in oligodendrocyte population density, but 
not in NG2 cell density, suggesting an additional defect in NG2 cell differentiation and/or 
oligodendrocyte survival. Lastly, through transmission electron microscopy, we observed large, 
misshapen myelinated axons around the corticospinal tract of the spinal cord. Our findings 
suggest that vesicle-associated membrane proteins in NG2 cells play a key role in myelination, 
NG2 cell differentiation, and/or oligodendrocyte survival, possibly mediated by exocytotic 





NG2 cells, also known as polydendrocytes or oligodendrocyte progenitor cells (OPCs), 
are a major glial population comprising 5-8% of glial cells in the central nervous system (CNS) 
(Levine et al., 2001). NG2 cells differentiate into oligodendrocytes, the myelinating cells of the 
CNS, both embryonically and throughout life (Bergles and Richardson, 2015; Murphy and 
Franklin, 2017). Their role as progenitor cells is therefore essential for myelination of axons in 
the brain and spinal cord, making them a highly relevant therapeutic target for the treatment of 
multiple sclerosis (MS), a chronic demyelinating disease affecting millions worldwide.  
The Identify of NG2 Cells 
Despite their prevalence in the CNS, NG2 cells have only recently been recognized as a 
major glial population distinct from oligodendrocytes, astrocytes, and microglia (Nishiyama et 
al., 1999). However, over the decades from their discovery, much information about this fourth 
major glial cell type has come to light. Their namesake is derived from their expression of 
neuron-glial antigen 2 (NG2), also known as chondroitin sulfate proteoglycan 4 (CSPG4). While 
pericytes also express CSPG4, NG2 glia can be easily distinguished by their expression of 
platelet-derived growth factor receptor alpha (PDGFRa), a receptor tyrosine kinase, as well as 
OLIG2, a basic helix-loop-helix transcription factor expressed throughout the entirety of the 
oligodendrocyte lineage. As NG2 cells differentiate into oligodendrocytes, NG2 and PDGFRa 
expression are downregulated (Levine and Stallcup, 1987; Stallcup and Beasley, 1987), while 
expression of myelin regulatory factor (MYRF) and the oligodendrocyte antigen CC1 are 
upregulated (Bhat et al., 1996). 
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The Uncertain Role of NG2 Cells in the Neural Network 
NG2 cells express numerous receptors for the neurotransmitters glutamate and GABA 
(Lin and Bergles, 2004; Steinhäuser and Gallo, 1996), and many neurons form direct synapses 
with NG2 cells (Bergles et al., 2000; Bergles et al., 2010; Ge et al., 2006). Additionally, 
exogenously applied glutamate and GABA have been shown to elicit Ca2+ transients in NG2 
cells (Cheli et al., 2015; Harlow et al., 2015; Sun et al., 2016). The consequences of this neuron-
glia synapses and Ca2+ transients in NG2 cells are currently unclear, and studies thus far have 
focused almost entirely on one-sided communication from neurons to NG2 cells.  
Despite thorough characterization of NG2 cell gene expression to the point of distinction 
as a major glial population, very little is known about the actual function of NG2 cells beyond 
their role as oligodendrocyte progenitors. Recent studies suggest potential trophic actions in the 
normal CNS (Birey et al., 2015; Djogo et al., 2016; Fernandez-Castaneda and Gaultier, 2016), 
and others have demonstrated the release of factors such as matrix metalloproteinase 9 (MMP9) 
in disease states (Seo et al., 2013).  
However, few studies have assayed for secreted factors, and few if any published works 
have investigated the mechanism or consequences of neuroactive or autocrine factor secretion by 
NG2 cells. NG2 cells express many genes and proteins associated with exocytotic machinery in 
neurons and astrocytes, including synaptophysin (Hamilton et al., 2010; Wigley and Butt, 2010), 
vesicular glutamate transporter VGLUT1 (Elsayed et al., 2012; Haberlandt et al., 2011), voltage-
dependent Ca2+ channels such as Cav1.2 (Barres et al., 1990; Cheli et al., 2016; Larson et al., 
2016), and vesicle-associated membrane proteins 2 and 3 (VAMP2 and 3) (Madison et al., 1999), 
among many others, but the functions of these proteins in NG2 cells are still unclear. Taking all 
of this information into account, we hypothesized that OPCs may be capable of Ca2+-dependent 
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exocytosis, and that blocking this process could inhibit trophic support functions usually 
provided by NG2 cells. 
Mouse Lines and Effect of BoNT/B Toxin 
In order to investigate the potential for Ca2+-dependent exocytosis in NG2 cells, our lab 
had generated a double transgenic IBOT:NG2creER line by crossing our NG2creER single 
transgenic line (Jackson Labs #008538) (Zhu et al., 2011), which expresses tamoxifen-inducible 
cre recombinase under the control of the Cspg4 (NG2) promoter, with the IBOT single 
transgenic line (Jackson Labs #010856). The IBOT line which contains a cre-inducible 
botulinum toxin that can be visualized with an internal ribosome entry site (IRES)-linked 
enhanced green fluorescent protein (EGFP) (Figure 1A), has been shown to cleave vesicle-
associated membrane proteins (VAMPs) in neurons and retinal glia when crossed to specific 
transgenic cre lines (Slezak et al., 2012), making it a promising candidate for application in NG2 
glia given their similarities in exocytotic protein expression. Our lab also generated a double 
transgenic IBOT:NG2cre line by crossing the aforementioned IBOT single transgenic line with 
our NG2cre single transgenic line (Jackson Labs #008533) (Zhu et al., 2008), which expresses 








Figure 1. Generation of the IBOT:NG2cre and IBOT:NG2creER Lines 
A) Transgenic mice were generated by crossing an IBOT line (Slezak et al., 2007), which 
contains a cre-inducible botulinum toxin that can be visualized with internal ribosome entry site 
(IRES)-linked enhanced green fluorescent protein (EGFP), with either NG2cre or NG2creER 
single transgenic mice, which express constitutive and tamoxifen-inducible cre recombinase, 
respectively. B) The toxin functions by cleaving vesicle-associated membrane proteins (VAMPs), 
SNARE proteins necessary for vesicle docking during Ca2+-dependent exocytosis in neurons, but 
with a currently unknown function in NG2 cells. C) Transgene specificity was confirmed by 
immunostaining for colocalization of GFP (green) with Olig2 (blue) alongside either NG2 or 
CC1 (red). 









Male and female IBOT:NG2creER double transgenic mice and NG2creER single 
transgenic littermates were used between postnatal days (P) P2-8, P8-17, P30-38, or P92-101. 
Male and female IBOT:NG2cre double transgenic mice and NG2cre single transgenic littermates 
were used at postnatal (P) days P10, P13, P14, P16, and P21. Housing, handling, care, and 
processing of animals were carried out in accordance with regulations approved by the 
Institutional Animal Care and Use Committee (IACUC) at the University of Connecticut. 
Tamoxifen Injections 
In order to activate cre recombinase and induce transgene expression in IBOT:NG2creER 
animals, we injected the estrogen analogues tamoxifen and 4-hydroxytamoxifen. Tamoxifen and 
4-hydroxytamoxifen (4-OHT) were dissolved in a 19:1 mixture of canola oil and ethanol and 
sonicated prior to every injection. P2 and P8 animals were injected intraperitoneally with 0.2 mg 
4-hydroxytamoxifen (10 mg/mL stock), while P30 and P92 animals were injected with 60 mg/kg 
tamoxifen (40 mg/mL stock). Control animals were injected with 19:1 canola oil:ethanol without 
tamoxifen. All animals were injected once each day for four consecutive days, then perfused four 
to six days after the final injection.  
Immunohistochemistry 
 To validate specific expression of the IBOT transgene (marked by EGFP) and investigate 
the effects of transgene expression on CNS cell populations and myelination, we immunostained 
brain and spinal cord sections from IBOT:NG2creER and IBOT:NG2cre animals prior to 
analysis with fluorescent and confocal microscopy. 
Tissue Collection and Fixation 
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P17, P38, and P101 IBOT:NG2creER animals and P10, P13, P14, and P21 IBOT:NG2cre 
animals were anesthetized with isoflurane and transcardially perfused with freshly prepared 4% 
paraformaldehyde (PFA) in 0.1 M sodium phosphate buffer. Spinal cords were extracted through 
laminectomy and postfixed alongside brains in chilled 4% PFA on a rotator for 2 hours, washed 
three times (10 minutes per wash) in cold 0.2 M sodium phosphate buffer, then processed for 
under either free-floating or cryosectioning protocols. 
Processing of Free-Floating Tissue 
 Following the three washes with 0.2 M sodium phosphate buffer, the tissue was left in 
fresh 0.2 M sodium phosphate buffer overnight at 4°C. The next day, brains were embedded in 
1% agarose and cut into 50 μm-thick sections using a Leica 1000 S vibratome before being 
placed in cryostorage solution and left at -20°C until staining. 
Processing of Cryosections 
Following the three washes with 0.2 M sodium phosphate buffer, the tissue was left in 
30% sucrose in 0.2 M sodium phosphate buffer at 4°C until all tissue sunk to the bottom of the 
polyethylene vial. Spinal cords were then sectioned into ~3 mm segments and embedded in 
optimal cutting temperature compound (OCT, Sakura) before being frozen using a mixture of dry 
ice and methanol and stored at -80°C until cryosectioning. 20 μm-thick transverse sections were 
cut using a Leica 3050S Cryostat, collected on Fisherbrand Superfrost Plus Microscope Slides, 
and stored at -20°C until staining.  
Primary and Secondary Antibodies 
Primary antibodies used included rabbit IgG anti-NG2 (1:500, Millipore), chicken IgY 
anti-GFP (1:1000, Aves), mouse IgG2b anti-APC/CC1 (1:200, Calbiochem), rabbit IgG anti-
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OLIG2 (1:500, Abcam), rabbit IgG anti-OLIG2 (1:500, Novus), mouse IgG2a anti-OLIG2 
(1:500, Millipore), goat IgG anti-mouse PDGFRa (1:500, R&D Systems), mouse IgG2b anti-
SMI99 (1:2000, Biolegend), rabbit pAb anti-Aldh1l1 (1:1000, Abcam), rabbit IgG anti-NeuN 
(1:300, Cell Signaling Technology), goat IgG anti-IBA1 (1:500, Thermo Fisher Scientific), 
rabbit pAb anti-GST-π (1:200, MBL International Corporation), rabbit pAb anti-MBP (1:200, 
Chemicon). Secondary antibodies used included Cy3 anti-rabbit IgG (1:500, Jackson), Cy3 anti-
mouse IgG1 (1:500, Jackson), Cy3 anti-mouse IgG2a (1:500, Jackson), Cy3 anti-mouse IgG2b 
(1:500, Jackson) Cy3 anti-goat IgG (1:500, Jackson), AlexaFluor488 anti-chicken IgY (1:1000, 
Aves), Alexa633 anti-rabbit IgG (1:200, Jackson), Alexa633 anti-mouse IgG1 (1:200, Jackson), 
Alexa633 anti-mouse IgG2a (1:200, Jackson), Alexa 647 anti-mouse IgG2b (1:200, Jackson), 
Alexa647 anti-rabbit IgG (1:200, Jackson), Alexa647 anti-mouse IgG1 (1:200, Jackson), 
Alexa647 anti-mouse IgG2a (1:200, Jackson), and Alexa647 anti-mouse IgG2b (1:200, Jackson). 
Primary Antibody Staining (Free-Floating) 
 Brain sections from different animals were placed in separate wells of 12-well plates 
filled with 0.1% Triton X-100 in PBS and washed three times (10 minutes per wash) on a rocker. 
They were then blocked for 1 hour in 5% normal goat serum (NGS) in 0.1% Triton X-100 in 
PBS, incubated overnight at 4°C in primary antibody solution consisting of three of the above 
antibodies, 5% NGS, and 0.1% Triton X-100 in PBS. 
Secondary Antibody Staining and Mounting (Free-Floating) 
Slides were washed three times (10 minutes per wash) with 1X PBS, blocked for 1 hour 
in 5% normal goat serum (NGS) in 1% Triton X-100 in PBS, and incubated overnight at room 
temperature (RT) in a humid staining chamber in primary antibody solution consisting of three of 
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the above antibodies, 5% NGS, and 1% Triton X-100 in PBS. Sections were then washed three 
times (5 minutes per wash) with 0.1% Triton X-100 in PBS and incubated for 1 hour at RT in 
secondary antibody solution consisting of three of the above antibodies, 5% NGS, and 0.1% 
Triton X-100 in PBS. Finally, sections were washed three times (5 minutes per wash), rinsed 
briefly with ddH2O, mounted on glass slides, let dry before being coverslipped with Vectashield 
containing 4’6-diamidino-2-phenylindole (DAPI) (Vector Laboratories), left to dry for ~15 
minutes, and had their edges sealed with nail polish before being stored at -20°C. 
Primary Antibody Staining (Cryosections) 
Slides were left to thaw ~10 minutes, then tissue was outlined using a pap pen and left to 
dry ~10 minutes before beginning staining protocol. Slides were washed three times (10 minutes 
per wash) with 1X PBS, incubated for 1 hour in 5% normal goat serum (NGS) in 1% Triton X-
100 in PBS, and incubated overnight at room temperature (RT) in a humid staining chamber in 
primary antibody solution consisting of two to three of the above antibodies, 5% NGS, and 1% 
Triton X-100 in PBS.  
Secondary Antibody Staining and Mounting (Cryosections) 
The next day, slides were washed three times (10 minutes per wash) with 1X PBS before 
being incubated for 1 hour in secondary antibody solution consisting of two to three of the above 
antibodies, 5% NGS, and 0.3% Triton in PBS. Slides were then washed three times (10 minutes 
per wash) with 1X PBS and one time with ddH2O (5 minutes). Slides were left to dry before 
being coverslipped with Vectashield containing 4’6-diamidino-2-phenylindole (DAPI) (Vector 
Laboratories), left to dry for ~15 minutes, and had their edges sealed with nail polish before 
being stored at -20°C. 
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Imaging and Quantification 
Stained slides were imaged using either a Zeiss Axiovert 200M fluorescent microscope 
with an Orca ER camera (Hamamatsu) and Apotome grid confocal system (Zeiss) or a Leica SP8 
confocal microscope. NG2+OLIG2+ or PDGFRa+OLIG2+ cells were considered NG2 cells, 
CC1+OLIG2+ or GST-π+OLIG2+ cells were considered mature oligodendrocytes, 
ALDH1L1+OLIG2- cells were considered astrocytes, IBA1+OLIG2- cells were considered 
microglia, and NEUN+OLIG2- cells were considered neurons. For quantification, the dorsal 
column of transverse spinal cord section used was outlined in Axiovision or ImageJ software, 
and cell density was derived from the number of cells over the area times the thickness of the Z-
stack. 
Transmission Electron Microscopy (TEM) 
 While light microscopy is ideal for quantifying cell populations and overarching structure 
in fixed tissue, it is limited in its potential magnification and resolution. Thus, in order to 
investigate the morphology of individual axons and myelin sheaths, we processed tissue for 
analysis through transmission electron microscopy (TEM).  
Tissue Collection and Fixation 
P16 animals were transcardially perfused with 4% PFA and 2% glutaraldehyde (GA) in 
0.1 M sodium cacodylate buffer with 2 mM CaCl2 and 4 mM MgCl. Spinal cords were extracted 
through laminectomy, cut into ~1 mm-thick segments, and postfixed overnight at 4°C in the 




Tissue was placed in a basket with mesh-wells and washed three times (15 minutes per 
wash) with 0.1 M sodium cacodylate buffer. The tissue was incubated for 1 hour in 1% osmium 
tetroxide and 0.8% potassium ferricyanide (KFe) solution in 0.1 M sodium cacodylate buffer, 
washed five times (5 minutes per wash) in 0.1 M sodium cacodylate buffer, incubated for 1 hour 
in 1% osmium tetroxide without KFe in 0.1 M sodium cacodylate buffer, and washed five times 
(5 minutes per wash) with 0.1 M sodium cacodylate buffer. 
Dehydration 
The tissue was rinsed twice (30 seconds each) with ddH2O, then underwent serial 
dilutions for 10 minutes each as follows: 50% ethanol in ddH2O, 70% ethanol in ddH2O, 90% 
ethanol in ddH2O, 100% ethanol, 1:1 ethanol:acetone, 1:2 ethanol:acetone, 100% acetone, 100% 
acetone, and 100% acetone). 
Infiltration 
Epon (WPE 145) resin was prepared fresh from a mixture of LX112 resin, dodecenyl 
succinic anhydride (DDSA), and nadic methyl anhydride (NMA). Tissue was incubated for 1 
hour in a 1:1 mixture of acetone:Epon, then overnight in a 1:4 mixture of acetone:Epon. 
Embedding 
The tissue was transferred to a dish of pure Epon for 1 hour, then to coffin molds 
containing pure Epon. The molds were placed at 60°C for 48 hours. 
Sectioning and Staining 
Ultrathin (~70 nm) sections were cut from each sample using a Leica Ultracut UCT 
ultramicrotome & collected on 200-mesh grids (Ted-Pella). Grids were left to dry overnight, then 
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stained for 8 minutes in 4% uranyl acetate, rinsed for 30 seconds with ddH2O, left to dry for 20 
min, stained for 4 minutes in 2.5% lead citrate, rinsed for 30 seconds with ddH2O, & stored at 
RT until the time of imaging. 
Imaging and Quantification 
Sections were imaged using a Thermo Fisher Scientific Technai T12 Transmission 
Electron Microscope. 9300x magnification images of dorsal column white matter were imported 
into Reconstruct (Synapseweb), and areas were derived from traces of myelinated axons with 
and without their myelin sheaths. 
RESULTS 
IBOT:NG2creER Mice 
 To validate specific expression of the IBOT transgene (marked by EGFP) and investigate 
the effects of transgene expression on CNS cell populations and myelination, we immunostained 
brain and spinal cord sections from IBOT:NG2creER and IBOT:NG2cre animals prior to 
analysis with fluorescent and confocal microscopy. As expected, GFP+Olig2+ cells were only 
observed in tamoxifen-injected IBOT:NG2creER double transgenic animals and not in single 
transgenic or vehicle-injected animals. However, the animals we used initially, aged P92-101, 
exhibited extremely low induction efficiency. Only ~4% of NG2+ cells in the corpus callosum 
and ~2% of NG2+ cells in the cortex were also GFP+ (Figure 2). In contrast, animals injected 
with 4-OHT from P8-11 and perfused at P17 displayed ~30% colocalization between NG2 and 
GFP. This could be attributed to a combination of the increased efficacy of 4-OHT and 
significantly shorter cell cycles of NG2 cells in young animals compared to adults (Psachoulia et 
al., 2009). In an attempt to produce an induction efficiency above 50%, we next attempted to 
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injected P2 animals with 4-OHT. However, none of the animals survived after more than three 
days of injections. Thus, we shifted our focus toward the IBOT:NG2cre constitutive cre line, in 
which all NG2-expressing cells and their progeny should be vulnerable to the transgene as early 
as embryonic day 14, when NG2 is first detectable in the CNS (Dawson et al., 2000; Nishiyama 
et al., 1996). 
    
 
 
Figure 2. Low transgene induction efficiency in IBOT:NG2creER animals 
While EGFP (green) staining indicative of transgene expression colocalized with Olig2 (blue) 
and NG2 (red) staining, overall induction efficiency was extremely low in adult 
IBOT:NG2creER animals, with only 4% of NG2+Olig2+ cells in the corpus callosum (CC, top) 
and 2% of NG2+Olig2+ cells in the cortex (bottom).  
Physical Phenotype of IBOT:NG2cre Mice  
IBOT:NG2cre, which differ from the IBOT:NG2creER mice above in their constitutive 
rather than tamoxifen-activated cre activity, exhibited severe motor defects and growth 













Figure 3. Phenotype of IBOT:NG2cre mice 
Compared to WT mice (A), IBOT mice (B) exhibited severe symptoms of limb weakness and lack 
of motor coordination, and were unable to right themselves when placed on their backs. C) IBOT 
mice (orange) experienced growth retardation compared to WT littermates (blue), with 
symptoms becoming apparent by ~P7 and growing increasingly severe until their deaths by 
~P21.  
Hypomyelination of the Spinal Cord 
In order to investigate the cause of the motor deficits seen in the IBOT:NG2cre line, we 
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normal in size and color, there was a striking difference in the appearance of the spinal cords. 
Compared to the solid-white WT spinal cords, IBOT spinal cords were nearly transparent (Figure 
4A), which led us to look specifically at myelination. Upon immunostaining with an antibody 
against myelin basic protein, we observed sparse, patchy myelination around the dorsal, ventral, 
and lateral funiculi, with a particularly noticeable lack of MBP in the ventral portion of the 
dorsal column (Figure 4B). In mice, this region contains the corticospinal tract (CST), a 
descending tract from the motor cortex necessary for control of the limbs (Steward et al., 2008). 
The observed myelination strongly suggested defects in myelinating oligodendrocytes as a result 
of transgene expression. 
     
Figure 4. Hypomyelination of the spinal cord in IBOT mice 
A) By P13, IBOT spinal cords (right) were myelin-deficient to the point of near-transparency 
compared to WT spinal cords (left). Immunostaining against myelin basic protein revealed 
sparse, patchy myelination throughout the anterior and dorsolateral funiculi of IBOT spinal 




Decreased Density of Oligodendrocytes but Not NG2 Cells 
 To identify the cause of the hypomyelination, we first investigated oligodendrocyte 
lineage cell population density, as the most straightforward cause of hypomyelination would be a 
deficiency in myelinating oligodendrocytes. We perfused IBOT:NG2cre double transgenic 
(IBOT) mice and NG2cre single transgenic (control) littermates at P14 and P21 and stained 
transverse spinal cord sections with antibodies against NG2, CC1, GFP, and Olig2. We imaged 
sections on a Zeiss Axiovert 200M fluorescent microscope and quantified oligodendrocyte 
lineage cell population density in the dorsal column by counting NG2+Olig2+ cells and 
CC1+Olig2+ cells and dividing by the volume of the dorsal column. As expected, we observed 
significantly lower CC1+Olig2+ populations in IBOT:NG2cre mice compared to control 
littermates at both P14 (Welch’s t-test, p = 0.0102) and P21 (Welch’s t-test, p = 0.0052) (Figure 
5). Interestingly, however, NG2 cell population density did not differ significantly between 
IBOT and control mice at P14 (Welch’s t-test, p = 0.4619) nor at P21 (Welch’s t-test, p = 
0.3807), and while not statistically significant, NG2 cell population density was actually greater 
















Figure 5. Quantification of oligodendrocyte and NG2 cell populations 
A-C. Immunostaining for the oligodendrocyte antigen CC1 in the dorsal column of WT (A) and 
IBOT (B) spinal cords. The density of CC1+ oligodendrocytes was severely reduced in IBOT 
dorsal columns at P14 (control n≥4, *** p<0.01) D-F) Immunostaining for NG2 in the dorsal 
column of the spinal cord of WT (C) and IBOT (D) mice at P14. F. The density of NG2 cells was 





Differences in Axon Area but not Myelin G-Ratio 
In order to better characterize our established hypomyelinating phenotype and to 
investigate possible axonal defects in IBOT animals, we processed P16 spinal cord tissue for 
transmission electron microscopy (TEM). TEM imaging showed a significantly lower density of 
both myelinated and unmyelinated axons in IBOT animals compared to WT animals. 
Interestingly, while more scarce, IBOT axons were significantly greater in area than WT axons 
(Figure 6C). Despite this difference, however, the myelin G-ratio, defined as the diameter of the 
axon to the diameter of the axon plus its myelin sheath, did not differ significantly between 
IBOT and WT animals (Figure 6D). Thus, it appears that while fewer axons were myelinated, 






Figure 6. Differences in axon area but not myelin G-ratio 
While the number of myelinated dorsal column axons was far greater in WT mice, average axon 
area was significantly greater in IBOT mice (Mann-Whitney U = 266, n1 = 49, n2 = 46, p < 
0.0001, two-tailed). However, the myelin G-ratio, defined as the diameter of the axon divided by 
the diameter of the axon plus its myelin sheath) did not differ significantly between genotypes 
(Mann-Whitney U = 1031, n1 = 49, n2 = 46, p = .4787, two-tailed). 
DISCUSSION 
Interestingly, we observed a significant decrease in oligodendrocyte density, but no 
change in NG2 cell density in the spinal cord dorsal columns of IBOT:NG2cre mutants. This 
suggests a disruption during oligodendrocyte lineage cell maturation. There are a few 
possibilities, but the most direct are: (A) NG2 cells are maintaining a static population due to an 
inability to differentiate, (B) NG2 cells are dying before differentiation but rapidly proliferating 
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after becoming oligodendrocytes. Our lab is currently working on EDU pulse chase and 
TUNEL/Caspase3 staining to identify the nature of this maturation defect. 
The axonal swelling observed here through electron microscopy fits with other groups’ 
observations of Plp null mutant mice. Plp null mutants exhibited axonal swelling specifically in 
fully myelinated axons (Griffiths et al., 1999), and transplantation of Plp mutant 
oligodendrocytes into shiverer mice resulted in similar axonal swelling (Edgar et al., 2004).  
This suggests that in our model, the dysfunctional oligodendrocytes that survive to begin 
myelinating either fail to produce myelin properly or, after myelinating axons, die and fail to 
provide trophic support necessary for axonal health. As Nave & Trapp (2008) suggest, the 
myelin sheaths surrounding the axons may prevent access to outside nutrients, effectively 
dooming myelinated axons without proper glial support. 
CONCLUSIONS 
Cleavage of VAMP2 and VAMP3 in NG2 cells and their progeny resulted in growth 
retardation, pronounced motor defects, early death, severe hypomyelination of the spinal cord, 
significantly lower oligodendrocyte density but not NG2 cell density, a decrease in the density of 
spinal cord axons, and the development of large, abnomally-shaped axons among those that 
remained. My immunostaining experiments showed that while NG2 cell population density was 
unaffected by expression of the BoNT/B toxin, oligodendrocyte density was significantly lower 
in IBOT animals, indicating a deficit in the differentiation and/or survival of developing 
oligodendrocytes as a result of VAMP cleavage in NG2 cells. While this alone could suggest 
simply an autocrine function for VAMPs in developing oligodendrocytes, preliminary TEM 
analysis suggested otherwise. The total number of dorsal column axons in IBOT mice was 
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significantly lower than that observed in WT animals, and many of the remaining axons 
appeared swollen and misshapen, suggesting declining neuronal health.  
Despite the observation of this striking phenotype, it should be noted that my work thus 
far is quite limited in scope. While the initial goal of the study was to investigate the potential for 
calcium-dependent exocytosis in NG2 cells, my experiments thus far only highlight the 
importance of VAMPs in NG2 cells and their progeny. At present, we have no direct evidence of 
calcium-dependent exocytosis in NG2 cells, much less the involvement of VAMPs in this 
hypothetical process. We also have yet to identify where along the oligodendrocyte lineage the 
mutant cells are malfunctioning and the precise mechanism by which VAMP cleavage leads to 
our phenotype. Taken together, our findings highlight a seemingly critical role of VAMP 
expression in NG2 cells not only in their own survival and differentiation, but also in axonal 
health. However, much work remains to be done in order to properly characterize the specific 
developmental functions of VAMPs in oligodendrocyte lineage cells. 
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